Pharmaron Beijing Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 3,585.968 million compared to CNY 2,626.486 million a year ago. Operating income was CNY 897.774 million compared to CNY 379.592 million a year ago. Net income was CNY 789.043 million compared to CNY 328.380 million a year ago. Basic earnings per share from continuing operations was CNY 0.9976 compared to CNY 0.506 a year ago. Diluted earnings per share from continuing operations was CNY 0.9951 compared to CNY 0.506 a year ago.